STOCK TITAN

Healthstream 8-K Filings

HSTM NASDAQ

Every 8-K that Healthstream (HSTM) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow HSTM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HSTM filings page.

Rhea-AI Summary

HealthStream reported record second-quarter 2026 revenue of $83.7 million, up 12.5% from the second quarter of 2025, with net income of $6.7 million and diluted EPS of $0.23. Adjusted EBITDA rose to $20.6 million, up 16.9%, as operating income increased 41.4% to $8.3 million.

For the first six months of 2026, revenue grew to $164.9 million and net income to $12.6 million, with adjusted EBITDA of $40.7 million. At June 30, 2026, cash, cash equivalents, and marketable securities totaled $66.7 million, and the company had no outstanding indebtedness from borrowed money.

The board declared a quarterly dividend of $0.035 per share, payable August 28, 2026, and the company repurchased 432,476 shares in the first half of 2026 for $9.3 million. Full-year 2026 guidance was updated to revenue of $327.0–$332.0 million, net income of $19.5–$22.2 million, adjusted EBITDA of $74.0–$78.0 million, and capital expenditures of $31.0–$34.0 million.

Rhea-AI Summary

HealthStream, Inc. reported a cybersecurity incident in which an unauthorized third party accessed a limited portion of files on its corporate file servers. Based on the company’s investigation so far, customer-facing systems were not accessed or compromised, no protected health information under HIPAA has been identified as accessed or exfiltrated, and no files were encrypted. Product and service delivery and other business operations have continued without interruption.

The company believes certain employee information, billing-related information for some customers and vendors, and corporate and legal information were accessed and/or exfiltrated. Data for approximately 75 credentialing customers had been copied to the corporate file servers for conversion, analytics, and troubleshooting, and those customers have been notified. HealthStream has engaged cybersecurity and forensics specialists, informed law enforcement, and expects to incur expenses for response, remediation, and investigation. Based on information currently known, it does not expect a material adverse impact on its business, operations, or financial results.

Rhea-AI Summary

HealthStream, Inc. reported the final voting results from its May 28, 2026 annual meeting of shareholders. Director nominees received the following votes: A. Alex Jahangir had 22,452,989 votes for, 2,421,416 withheld, and 2,654,245 broker non-votes; Jeffrey L. McLaren had 14,484,114 for, 10,390,291 withheld, and 2,654,245 broker non-votes; and Linda Rebrovick had 23,316,490 for, 1,557,915 withheld, and 2,654,245 broker non-votes.

Shareholders also voted on two additional proposals. One proposal received 27,171,627 votes for, 355,926 against, and 1,097 abstentions with no broker non-votes. Another proposal received 23,852,346 votes for, 1,019,058 against, 3,001 abstentions, and 2,654,245 broker non-votes. Directors not up for election continue to serve on the Board.

Rhea-AI Summary

HealthStream, Inc. has promoted Michael M. Collier to Chief Operating Officer and Executive Vice President from his prior corporate strategy and operations role. He will oversee enterprise operations, including customer experience, corporate development, M&A, implementations, legal, HR, partnerships, business enablement, and other key functions.

Collier will also act as executive sponsor for the company’s AI transformation. In connection with his promotion, he received stock options for 18,781 shares at an exercise price of $23.96 per share under the 2022 Omnibus Incentive Plan, vesting over five years, and an increased base salary with eligibility for executive-level bonuses and time-based RSU awards.

The Compensation Committee also granted the CEO, Robert A. Frist, Jr., stock options for 18,781 shares at the same $23.96 exercise price, with identical five-year time-based vesting tied to continued service.

Rhea-AI Summary

HealthStream, Inc. reported strong growth for the first quarter of 2026 and reaffirmed its full-year 2026 outlook. Revenue rose to $81.2 million, up 10.5% from $73.5 million a year earlier, driven by higher subscription and professional services revenues, including contributions from the 2025 Virsys12 and MissionCare Collective acquisitions.

Operating income increased to $7.5 million, up 71.6%, while net income grew to $5.9 million and diluted EPS reached $0.20, compared with $0.14 in the prior-year quarter. Adjusted EBITDA climbed 24.1% to $20.1 million. The company ended March 31, 2026 with $66.5 million in cash, cash equivalents, and marketable securities and no debt.

HealthStream returned capital through share repurchases and dividends, buying back 342,345 shares for $7.5 million at an average price of $21.91 during the quarter and declaring a quarterly dividend of $0.035 per share, payable May 29, 2026. The board also authorized a new $10.0 million repurchase program and the company reaffirmed 2026 guidance for revenue of $323–$330 million, net income of $20.4–$22.8 million, adjusted EBITDA of $73–$77 million, and capital expenditures of $31–$34 million. Additionally, HealthStream promoted Michael M. Collier to Chief Operating Officer & Executive Vice President.

Rhea-AI Summary

HealthStream, Inc. entered into a First Amendment to its Amended and Restated Revolving Credit Agreement with Truist Bank. The amendment revises the restricted payments covenant to allow dividends and share repurchases that do not increase the Company’s pro forma leverage ratio above 1.50:1.00, and to permit additional restricted payments in an aggregate amount up to $50,000,000, in each case so long as no default or event of default exists.

The Board of Directors also approved a new share repurchase program authorizing the Company to buy back up to $10,000,000 of its outstanding common stock. Repurchases may be made in the open market, under Rule 10b5-1 plans, through privately negotiated transactions, or otherwise, and the program will terminate on the earlier of September 12, 2026 or when the authorized amount has been fully used.

Rhea-AI Summary

HealthStream, Inc. reported record fourth quarter 2025 revenue of $79.7 million, up 7.4% from 2024, but lower GAAP profits due mainly to a one-time $3.8 million CEO Stock Gift charge. Excluding this item, non-GAAP operating income rose to $6.2 million and non-GAAP EPS to $0.18 per diluted share.

For full-year 2025, revenue grew 4.3% to $304.1 million, with adjusted EBITDA up 7.5% to $71.8 million. The company ended the year with $57.0 million in cash, cash equivalents, and marketable securities, and repurchased 1,111,590 shares for $30.0 million.

HealthStream completed acquisitions of Virsys12 and MissionCare Collective and increased its quarterly dividend to $0.035 per share, payable March 20, 2026. For 2026, it guides to revenue of $323.0–$330.0 million, net income of $20.4–$22.8 million, and adjusted EBITDA of $73.0–$77.0 million.

Rhea-AI Summary

HealthStream, Inc. reported that it issued a press release announcing its acquisition of MissionCare Collective LLC, described as a healthcare workforce company. The press release, dated December 15, 2025, is attached as Exhibit 99.1 to this current report on Form 8-K. This reflects HealthStream’s use of a current report to inform investors about a corporate acquisition in the healthcare workforce space, with additional information available in the press release filed as an exhibit.

Rhea-AI Summary

HealthStream, Inc. announced a new share repurchase program authorizing the buyback of up to $10,000,000 of its outstanding common stock. The program will terminate on the earlier of February 26, 2026 or when the authorized amount has been fully used.

The authorization gives the company flexibility to return capital by repurchasing shares within the stated limit and timeframe.

Rhea-AI Summary

HealthStream, Inc. (HSTM) reported that it issued a press release announcing results for the third quarter ended September 30, 2025 and an update to full-year 2025 guidance. The press release is furnished as Exhibit 99.1.

The Board of Directors also declared a quarterly cash dividend of $0.031 per share of common stock. The dividend is payable on November 28, 2025 to shareholders of record as of November 17, 2025.

Rhea-AI Summary

HealthStream, Inc. filed an 8-K reporting that on October 8, 2025 the company issued a press release announcing it acquired Virsys12, LLC, a Tennessee limited liability company. The filing states the press release is attached as Exhibit 99.1 and incorporated by reference. No financial terms, purchase price, or changes to management or guidance are disclosed in the filing. The document is limited to the announcement of the acquisition and the exhibit; it does not include financial statements or details about the transaction's expected impact on revenue, expenses, or operations.